MindWalk Secures First Recurring LensAI Contract; Reports 52% Revenue Jump
HYFT•MindWalk has built a biological context layer spanning 660 million patterns and 25 billion relationships to power AI drug discovery. In fiscal Q3 ending January 31, 2026, the company reported CAD 4.2 million revenue—up 52% year-over-year with U.S. sales doubling—and secured its first one-year recurring LensAI contract.
1. Biological Context Layer Strategy
MindWalk's context layer unifies fragmented biological data into a queryable foundation of 660 million patterns and 25 billion relationships, linking sequences, structures, functions, mechanisms, pathways and evidence. This system feeds AI reasoning workflows to reduce hallucinations by grounding predictions in conserved evolutionary patterns rather than raw statistical correlations.
2. LensAI Contract Milestone
The company secured its first one-year recurring LensAI platform contract with a large enterprise client, marking its first contracted recurring platform revenue agreement. LensAI serves for target discovery, candidate diligence and portfolio decision support, positioning MindWalk to scale autonomous AI-driven research workflows.
3. Fiscal Q3 Financial Results
In fiscal Q3 ending January 31, 2026, MindWalk reported revenue of CAD 4.2 million, a 52% increase year-over-year, driven by strong U.S. sales growth that doubled compared to the prior year. This marks the third consecutive quarter of annual growth, underscoring accelerating platform adoption.
4. Real-World Validation and Panel Appearance
MindWalk also reported preclinical dengue data validating a computational prediction generated by its platform prior to animal immunization, providing early real-world proof of its approach. The company is set to present its thesis on biology, context and compute at a virtual investor panel on June 15, 2026.
